• Je něco špatně v tomto záznamu ?

Analytical quality by design in the development of a solvent-modified micellar electrokinetic chromatography method for the determination of sitagliptin and its related compounds

B. Pasquini, R. Gotti, M. Villar-Navarro, M. Douša, L. Renai, M. Del Bubba, S. Orlandini, S. Furlanetto

. 2021 ; 202 (-) : 114163. [pub] 20210524

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21018371

A solvent-modified micellar electrokinetic chromatography method was developed following the Quality by Design approach for the simultaneous determination of sitagliptin (SIT), an oral antihyperglycemic drug, and its main impurities derived from the synthesis process. The separation system was identified in the scouting phase and was made by sodium dodecyl sulphate (SDS) micelles with the addition of n-butanol and methanol. The knowledge space was investigated through an asymmetric screening matrix, taking into consideration eight critical method parameters (CMPs) involving the composition of the background electrolyte in terms of buffer concentration and pH, the concentration of surfactants and organic modifiers, and voltage. The critical method attributes (CMAs) were identified as analysis time and the distance between the tail of the electroosmotic flow system peak and the front edge of impurity I1 (sitagliptin triazole hydrochloride). A Box-Behnken Design was used in response surface methodology for calculating the quadratic models relating the CMPs to the CMAs. From the models it was possible to compute the method operable design region (MODR) through Monte-Carlo simulations. The MODR was identified in the probability maps as the multidimensional zone where the risk of failure to achieve the desired values for the CMAs was lower than 10 %. The experimental conditions corresponding to the working point, with the MODR interval, were the following: background electrolyte, 14 (10-18) mM borate buffer pH 9.20, 100 mM SDS, 13.6 (11.1-16.0) %v/v n-butanol, 6.7 (4.5-8.8) %v/v methanol; voltage and temperature were set to 28 kV and 22 °C, respectively. The developed CE method was validated in accordance with International Council for Harmonisation guidelines and was applied to the analysis of SIT tablets. The routine analysis for the quality control of the pharmaceutical product could be conducted in about 11 min.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018371
003      
CZ-PrNML
005      
20210830095945.0
007      
ta
008      
210728s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jpba.2021.114163 $2 doi
035    __
$a (PubMed)34052552
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Pasquini, Benedetta $u Department of Chemistry "U. Schiff", University of Florence, Via U. Schiff 6, Via della Lastruccia 3-13, 50019, Sesto Fiorentino, Florence, Italy. Electronic address: benedetta.pasquini@me.com
245    10
$a Analytical quality by design in the development of a solvent-modified micellar electrokinetic chromatography method for the determination of sitagliptin and its related compounds / $c B. Pasquini, R. Gotti, M. Villar-Navarro, M. Douša, L. Renai, M. Del Bubba, S. Orlandini, S. Furlanetto
520    9_
$a A solvent-modified micellar electrokinetic chromatography method was developed following the Quality by Design approach for the simultaneous determination of sitagliptin (SIT), an oral antihyperglycemic drug, and its main impurities derived from the synthesis process. The separation system was identified in the scouting phase and was made by sodium dodecyl sulphate (SDS) micelles with the addition of n-butanol and methanol. The knowledge space was investigated through an asymmetric screening matrix, taking into consideration eight critical method parameters (CMPs) involving the composition of the background electrolyte in terms of buffer concentration and pH, the concentration of surfactants and organic modifiers, and voltage. The critical method attributes (CMAs) were identified as analysis time and the distance between the tail of the electroosmotic flow system peak and the front edge of impurity I1 (sitagliptin triazole hydrochloride). A Box-Behnken Design was used in response surface methodology for calculating the quadratic models relating the CMPs to the CMAs. From the models it was possible to compute the method operable design region (MODR) through Monte-Carlo simulations. The MODR was identified in the probability maps as the multidimensional zone where the risk of failure to achieve the desired values for the CMAs was lower than 10 %. The experimental conditions corresponding to the working point, with the MODR interval, were the following: background electrolyte, 14 (10-18) mM borate buffer pH 9.20, 100 mM SDS, 13.6 (11.1-16.0) %v/v n-butanol, 6.7 (4.5-8.8) %v/v methanol; voltage and temperature were set to 28 kV and 22 °C, respectively. The developed CE method was validated in accordance with International Council for Harmonisation guidelines and was applied to the analysis of SIT tablets. The routine analysis for the quality control of the pharmaceutical product could be conducted in about 11 min.
650    12
$a chromatografie micelární elektrokinetická kapilární $7 D020374
650    12
$a micely $7 D008823
650    _2
$a reprodukovatelnost výsledků $7 D015203
650    _2
$a sitagliptin fosfát $7 D000068900
650    _2
$a dodecylsíran sodný $7 D012967
650    _2
$a rozpouštědla $7 D012997
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gotti, Roberto $u Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126, Bologna, Italy. Electronic address: roberto.gotti@unibo.it
700    1_
$a Villar-Navarro, Mercedes $u Department of Analytical Chemistry, University of Seville, c/Prof. García González, s/n., 41012, Seville, Spain. Electronic address: mvn@us.es
700    1_
$a Douša, Michal $u Zentiva, k.s. Praha, a Sanofi Company, U Kabelovny 130, 102 37, Praha 10, Czech Republic. Electronic address: michal.dousa@seznam.cz
700    1_
$a Renai, Lapo $u Department of Chemistry "U. Schiff", University of Florence, Via U. Schiff 6, Via della Lastruccia 3-13, 50019, Sesto Fiorentino, Florence, Italy. Electronic address: lapo.renai@unifi.it
700    1_
$a Del Bubba, Massimo $u Department of Chemistry "U. Schiff", University of Florence, Via U. Schiff 6, Via della Lastruccia 3-13, 50019, Sesto Fiorentino, Florence, Italy. Electronic address: massimo.delbubba@unifi.it
700    1_
$a Orlandini, Serena $u Department of Chemistry "U. Schiff", University of Florence, Via U. Schiff 6, Via della Lastruccia 3-13, 50019, Sesto Fiorentino, Florence, Italy. Electronic address: serena.orlandini@unifi.it
700    1_
$a Furlanetto, Sandra $u Department of Chemistry "U. Schiff", University of Florence, Via U. Schiff 6, Via della Lastruccia 3-13, 50019, Sesto Fiorentino, Florence, Italy. Electronic address: sandra.furlanetto@unifi.it
773    0_
$w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 202, č. - (2021), s. 114163
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34052552 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830095945 $b ABA008
999    __
$a ok $b bmc $g 1689486 $s 1138815
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 202 $c - $d 114163 $e 20210524 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...